The receptor for Interleukin-17E is induced by Th2 cytokines in antigen-presenting cells

被引:49
作者
Gratchev, A [1 ]
Kzhyshkowska, J [1 ]
Duperrier, K [1 ]
Utikal, J [1 ]
Velten, FW [1 ]
Goerdt, S [1 ]
机构
[1] Univ Heidelberg, Univ Med Ctr Mannheim, Dept Dermatol, D-6800 Mannheim, Germany
关键词
D O I
10.1111/j.0300-9475.2004.01443.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-17E (IL-17E) (IL-25) is a recently identified cytokine capable to induce Th2-associated cytokine production (IL-5 and IL-13) and T helper 2 (Th2)-type pathologies in animal models. The IL-17E-responsive cell population in vivo was described to be a further uncharacterized non-T-, non-B-splenic accessory cell. Despite the identification of IL-17BR as the receptor for IL-17E, the cell population expressing IL-17BR has hitherto not been identified. Here, we show that human monocyte-derived Th2-skewed antigen-presenting cells (APC2) express membrane-bound and soluble forms of IL-17BR on the mRNA and protein level upon stimulation with IL-4, IL-10, IL-13 or transforming growth factor-betain vitro. These results indicate that IL-17BR-expressing APC2s may mediate the development of the IL-17E-mediated immunological reaction patterns observed in vivo.
引用
收藏
页码:233 / 237
页数:5
相关论文
共 25 条
  • [1] A Brugia malayi homolog of macrophage migration inhibitory factor reveals an important link between macrophages and eosinophil recruitment during nematode infection
    Falcone, FH
    Loke, P
    Zang, XX
    MacDonald, AS
    Maizels, RM
    Allen, JE
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (09) : 5348 - 5354
  • [2] IL-25 induces IL-4 IL-5, and IL-13 and Th2-associated pathologies in vivo
    Fort, MM
    Cheung, J
    Yen, D
    Li, J
    Zurawski, SM
    Lo, S
    Menon, S
    Clifford, T
    Hunte, B
    Lesley, R
    Muchamuel, T
    Hurst, SD
    Zurawski, G
    Leach, MW
    Gorman, DM
    Rennick, DM
    [J]. IMMUNITY, 2001, 15 (06) : 985 - 995
  • [3] Other functions, other genes: Alternative activation of antigen-presenting cells
    Goerdt, S
    Orfanos, CE
    [J]. IMMUNITY, 1999, 10 (02) : 137 - 142
  • [4] Alternative activation of macrophages
    Gordon, S
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (01) : 23 - 35
  • [5] Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein βIG-H3
    Gratchev, A
    Guillot, P
    Hakiy, N
    Politz, O
    Orfanos, CE
    Schledzewski, K
    Goerdt, S
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 53 (04) : 386 - 392
  • [6] Alternatively activated antigen-presenting cells: Molecular repertoire, immune regulation, and healing
    Gratchev, A
    Schledzewski, K
    Guillot, P
    Goerdt, S
    [J]. SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2001, 14 (05): : 272 - 279
  • [7] Soluble and transmembrane Isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer
    Haudenschild, D
    Moseley, T
    Rose, L
    Reddi, AH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (06) : 4309 - 4316
  • [8] New IL-17 family members promote Th1 or Th2 responses in the lung: In vivo function of the novel cytokine IL-25
    Hurst, SD
    Muchamuel, T
    Gorman, DM
    Gilbert, JM
    Clifford, T
    Kwan, S
    Menon, S
    Seymour, B
    Jackson, C
    Kung, TT
    Brieland, JK
    Zurawski, SM
    Chapman, RW
    Zurawski, G
    Coffman, RL
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (01) : 443 - 453
  • [9] Mast cells produce interleukin-25 upon FcεRI-mediated activation
    Ikeda, K
    Nakajima, H
    Suzuki, K
    Kagami, SI
    Hirose, K
    Suto, A
    Saito, Y
    Iwamoto, I
    [J]. BLOOD, 2003, 101 (09) : 3594 - 3596
  • [10] The soluble interleukin 6 receptor: mechanisms of production and implications in disease
    Jones, SA
    Horiuchi, S
    Topley, N
    Yamamoto, N
    Fuller, GM
    [J]. FASEB JOURNAL, 2001, 15 (01) : 43 - 58